Skip to content
GLP-1 Savers
Menu
Ranked #44 · Good Value

Vytora Health review

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $180/mo

Save ~87% vs brand-name

From $180/mo (all doses, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The rate is stated as the same at every dose, but it is not a plain month-to-month figure, it is tied to a longer commitment rather than month-to-month billing.

How much does Vytora Health cost?

The price Vytora Health publishes is From $180/mo (all doses, compounded). Tirzepatide is listed at From $249/mo (all doses, compounded). We flag this one to watch: confirm the ongoing rate with Vytora Health before you count on it, because a low first month can step up afterward. That works out about 87% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $180/mo (all doses, compounded)
Tirzepatide
From $249/mo (all doses, compounded)
Coverage
All 50 states
Brand-name
Yes

The Value Score card

Vytora Health scored on our six published factors. See the methodology.

Lowest Real Price76/100
No Teaser-Rate Bait80/100
Nationwide Availability96/100
Both Molecules92/100
Easy Cancellation68/100
Reputation95/100

Why it's a deal

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Read the fine print

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

The bottom line

Best for: Shoppers who want compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides.

Ranked #44 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Vytora Health, out of 426 others we track.

Shopping Vytora Health against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Vytora Health, and every program that undercuts or outscores it — starting with Fifty 410, the closest match on score — is ranked on the Vytora Health alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Vytora Health's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Vytora Health's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals